跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 21,244 条关于
“AdaptPD CHO-MK Platform Media”
全部
21,244
临床试验
8,338
药物
1,637
机构
1,586
资讯
9,683
9个月前
Chitose Laboratory and Fujifilm Biosciences Form Strategic Alliance to Advance Biopharmaceutical Manufacturing
去年
Asimov Expands Strategic Partnerships to Accelerate Biologics Development Through CHO Edge Platform
5个月前
Thermo Fisher Scientific Launches Next-Generation Cell Line Development Platform to Accelerate Biologics Manufacturing
上个月
David Sinclair Launches Lifespan, a Scientist-Led Media Platform, as First Human Epigenetic Reprogramming Trial Advances
去年
Lantheus' Alzheimer's Radiodiagnostic MK-6240 Achieves Pivotal Study Success, NDA Filing Planned
5个月前
Merck Discontinues In-House TROP2 ADC MK-6837 After Revealing Dual Development Strategy
去年
CHO Plus Secures U.S. Patent for Engineered Yeast Cell Technology to Boost Protein Production
去年
Clesrovimab Shows Promise in Preventing RSV Infections in Infants
去年
CHO Plus Secures $10.4M BARDA Contract to Develop Cell Lines for Filovirus Monoclonal Antibody Production
9个月前
Merck Receives FDA Fast Track Designation for Novel Alzheimer's Tau-Targeting Antibody MK-2214
第 1 页，共 969 页
上一页
下一页
